Castleark Management’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-75,676
Closed -$3.75M 412
2016
Q4
$3.75M Sell
75,676
-13,545
-15% -$687K 0.12% 222
2016
Q3
$4.68M Sell
89,221
-6,810
-7% -$334K 0.14% 185
2016
Q2
$4.29M Sell
96,031
-15,110
-14% -$657K 0.14% 189
2016
Q1
$4.55M Buy
111,141
+14,521
+15% +$535K 0.14% 188
2015
Q4
$3.53M Buy
+96,620
New +$3.49M 0.11% 210
2015
Q1
Sell
-49,800
Closed -$1.9M 383
2014
Q4
$1.9M Buy
+49,800
New +$1.82M 0.05% 243
2014
Q3
Sell
-10,700
Closed -$418K 345
2014
Q2
$418K Buy
+10,700
New +$400K 0.01% 282
2013
Q4
Sell
-10,700
Closed -$380K 396
2013
Q3
$380K Buy
+10,700
New +$285K 0.01% 304

Other funds holding XYL

Castleark Management's XYL Position: Q1 2017 in Review

Castleark Management sold out of Xylem (XYL) in Q1 2017, closing a stake of 75,676 shares — an estimated $3.75M sold.

Castleark Management first reported a position in XYL in Q3 2013 and held it in 8 quarters. The position peaked at $4.68M in Q3 2016. 546 funds tracked by Wall St. Rank hold XYL as of Q1 2017.

  • Castleark Management reported no remaining Xylem position as of Q1 2017 after selling out during the quarter.
  • Castleark Management sold 75,676 Xylem shares in Q1 2017, an estimated $3.75M.
  • Castleark Management first reported a position in Xylem in Q3 2013 and held it in 8 quarters.
  • Castleark Management's Xylem position peaked at $4.68M in Q3 2016.
  • 546 funds tracked by Wall St. Rank held Xylem as of Q1 2017.

Based on Castleark Management's 13F filing for Q1 2017, filed 15 May 2017.